Penalty Amount
$400,000,000
Attorney General Jennifer Davenport joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations of widespread price-fixing and anticompetitive conduct in the generic drug market. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to internal reforms to ensure fair competition.
Sandoz will pay $400 million as part of this settlement (with total payments of approximately $469 million including prior settlements) and has agreed to meaningful injunctive terms including internal reforms to ensure fair competition and compliance with antitrust laws.
In-house legal teams should review vendor and customer agreements in the pharmaceutical supply chain for any clauses that could facilitate price-fixing or market allocation, such as most-favored-nation clauses, resale price maintenance, or information sharing provisions. They should also ensure that compliance programs include antitrust training and that contracts include representations and warranties regarding compliance with antitrust laws. Additionally, any agreements with competitors, such as joint ventures or co-marketing arrangements, should be scrutinized for potential collusion risks.
Entity
Sandoz Inc.
Industry
HealthcareOfficial Press Release
https://www.njoag.gov/attorney-general-davenport-announces-400-million-settlement-in-principle-with-sandoz-over-conspiracy-to-inflate-prices-and-limit-competition/
GDMS First Amended Complaint
https://nj.gov/oag/newsreleases17/GDMS-First-Amended-Complaint.pdf
Complaint
https://www.nj.gov/oag/newsreleases19/Complaint.pdf
New Jersey Attorney General Enforcement Page
https://www.njoag.gov/about/divisions-and-offices/division-of-consumer-affairs/
"Sandoz Inc."
"$400 million settlement in principle"
"antitrust laws"
"conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"
$400.0M
Minnesota Attorney General Keith Ellison joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to injunctive terms and internal reforms.
$400.0M
Attorney General Tong led a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million total and implement internal reforms to ensure fair competition and compliance with antitrust laws.
$400.0M
Attorney General Phil Weiser joined a coalition of 43 states and territories announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million including previous settlements and agreed to meaningful reforms to ensure fair competition and compliance with antitrust laws.
A multistate coalition co-led by New Jersey won a federal court order rejecting the Trump Administration’s decision not to request funding for the CFPB. The order struck down that decision and directed the Administration to follow the law and fund the agency; no monetary penalty or privacy violation is described.
New Jersey’s Attorney General and Division of Consumer Affairs alerted the public that three synthetic kratom-related compounds became illegal to possess or sell in the state under a temporary federal scheduling order. The release describes a controlled-substance alert, not a privacy enforcement action, and identifies no company, privacy violation, or monetary penalty.
$2.3M
Laboratory Corporation of America Holdings agreed to pay $2,287,455 to participating states and strengthen its security and vendor-management practices following an investigation into the 2019 breach at its debt-collection vendor, AMCA. The breach potentially exposed information of more than 27.5 million people nationwide, including sensitive information belonging to approximately 10.2 million LabCorp patients.